Leef Brands (LEEEF) Total Liabilities (2024 - 2026)

Leef Brands (LEEEF) posted Total Liabilities of $47.6 million for Q1 2026, up 6.56% sequentially from $44.7 million in Q4 2025.

Leef Brands (LEEEF) Total Liabilities (2024 - 2026) Analysis & Trends

Leef Brands has reported Total Liabilities for 3 years, with the latest figure at $47.6 million in Q1 2026.

Quarterly Total Liabilities changed N/A year-over-year to $47.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.6 million (changed N/A YoY) and the FY2025 annual result came in at $44.7 million, down 19.38% from the prior year.
Total Liabilities rose to $47.6 million in Q1 2026 per LEEEF's latest filing, from $44.7 million in the prior quarter.
Over five years, Total Liabilities peaked at $55.4 million in Q4 2024 and troughed at $44.7 million in Q4 2025.
A 3-year average of $49.2 million and a median of $47.6 million in 2026 frame the typical range for Total Liabilities.
The widest YoY moves for Total Liabilities: up 19.38% in 2025, down 19.38% in 2025.
Over 3 years, Total Liabilities stood at $55.4 million in 2024, then slipped by 19.38% to $44.7 million in 2025, then grew by 6.56% to $47.6 million in 2026.
According to Business Quant data, Total Liabilities over the past three periods registered $47.6 million, $44.7 million, and $55.4 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Liabilities (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-21.66 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	32.10 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	11.93 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	50.85 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	819.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	20.78 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	1.67 Bn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	6.97 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	2.12 Bn
10	Leef Brands	59.45 Mn	54.50 Mn	2.41 Mn	54.45 Mn

Download Data